Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Stock Information for Veru Inc.
Loading
Please wait while we load your information from QuoteMedia.